Hans Weiher

Rheinbach, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Cytokine-induced killer (CIK) cells inhibit Plasmodium falciparum parasitemia through cytolytic effector activity in vitro.

Cytokine-induced killer (CIK) cells inhibit Plasmodium falciparum parasitemia through cytolytic effector activity in vitro.

Journal: Immunobiology
Published: June 03, 2025

Macrophage-derived pro-inflammatory cytokines augment the cytotoxicity of cytokine-induced killer cells by strengthening the NKG2D pathway in multiple myeloma.

Macrophage-derived pro-inflammatory cytokines augment the cytotoxicity of cytokine-induced killer cells by strengthening the NKG2D pathway in multiple myeloma.

Journal: Scientific reports
Published: December 10, 2024

Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.

Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 06, 2023

Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.

Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.

Journal: Frontiers in immunology
Published: July 28, 2023

Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.

Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.

Journal: Frontiers in immunology
Published: April 21, 2022

Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials.

Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials.

Journal: Cancers
Published: October 16, 2021

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.

Journal: Frontiers in immunology
Published: June 28, 2021

A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.

A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.

Journal: Frontiers in oncology
Published: May 23, 2021

Presence of the Transmembrane Protein Neuropilin in Cytokine-induced Killer Cells.

Presence of the Transmembrane Protein Neuropilin in Cytokine-induced Killer Cells.

Journal: Anticancer research
Published: June 02, 2020

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.

Journal: International journal of molecular sciences
Published: March 12, 2020

FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells.

FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells.

Journal: Anticancer research
Published: July 29, 2019

Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.

Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.

Journal: Oncology letters
Published: November 02, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026